Merk, page-8

Hi Lopez,

I am happy for criticism, but I would like the assertions backed up. This can be a discussion.

I cannot see how going to phase 3 has any major adverse affects other than money. The problem I see is lots of small players have a carrot dangled in front of them by major players. The major players are not always charitable and are in the game for different reasons to us. I see our best efforts are to get to it and make sure we have a product that works and is approved by FDA. The danger is that we may find out that it isnt as good as other drugs, this is the risk I am willing to take, I have confidence in the product.